Chidamide improves gefitinib treatment outcomes in NSCLC by attenuating recruitment and immunosuppressive function of myeloid-derived suppressor cells
2024 · Biomedicine & Pharmacotherapy · 10 citations
https://doi.org/10.1016/j.biopha.2024.116306
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
N Liu is an academic researcher.
Click to start Chat